Abciximab

Description

Short Overview

Abciximab is a chimeric monoclonal antibody fragment (Fab) known for its potent antiplatelet activity. It is extensively used in cardiovascular research settings to study platelet aggregation inhibition, thrombosis prevention, and glycoprotein IIb/IIIa receptor interactions. Manufactured with high purity standards, Abciximab peptide is supplied in lyophilized powder form for convenient handling and long-term stability in research settings.

Product Specifications

Product Name: Abciximab

Category: Peptide

CAS Number: 143653-53-6

Form: Lyophilized Powder

Purity: High-grade research quality

Storage: Store refrigerated (2-8 degrees C) for optimal stability

Available Variants

Key Features

• High-purity Abciximab peptide
• Lyophilized for improved stability and storage
• Consistent batch quality for research reliability
• Available in 5 mg and 10 mg vial packaging
• Secure packaging for laboratory use

Research Applications

• Abciximab is commonly used in studies involving:
• Platelet aggregation inhibition studies
• Cardiovascular thrombosis research
• Glycoprotein IIb/IIIa receptor binding assays
• Anticoagulant therapy modeling
• Acute coronary syndrome pathway studies

Handling and Storage

• Store in a cool and dry place.
• For long-term storage, keep at 2-8 degrees C or frozen.
• Avoid repeated freeze-thaw cycles.

Important Disclaimer

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or household use.